**We’re Raising Our Eli Lilly Price Target — What a Difference a Quarter Makes**
Eli Lilly’s Record Rally: Why We’re Raising Our Price Target In the fast-moving world of pharmaceuticals, few companies have captured investor optimism like Eli Lilly (NYSE: LLY). Over the past quarter, the Indiana-based drugmaker solidified…
